Azacitidine-Induced Pneumonitis in a Patient with Myelodysplastic Syndrome: First Case Report in Japan-Reference-Cited by-同舟云学术

Azacitidine-Induced Pneumonitis in a Patient with Myelodysplastic Syndrome: First Case Report in Japan

Published:2012 Issue:17 Volume:51 Page:2411-2415
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hayashi Makoto¹,Takayasu Hiromi¹,Tada Mami¹,Yamazaki Yohei¹,Tateno Hidetsugu¹,Tazawa Sakiko¹,Wakabayashi Aya¹,Iwasaki Takuya¹,Tsuchiya Yutaka¹,Yamashita Jun¹,Takeda Norikazu¹,Tomita Shogo¹,Mori Hiraku²,Kokubu Fumio¹

Affiliation:

1. Department of Respiratory Medicine, Showa University Fujigaoka Hospital, Japan

2. Department of Hematology, Showa University Fujigaoka Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/17/51_51.8167/_pdf

Reference23 articles.

1. 1. Von Hoff DD, Slavik M, Muggia FM. 5-Azacytidine a new anticancer drug with effectiveness in acute myelogeneous leukemia. Ann Intern Med 85: 237-245, 1976.

2. 2. Sullivan M, Hahn K, Kolesar JM. Azacitidine: A novel agent for myelodysplastic syndromes. Am J Health Syst Pharm 62: 1567-1573, 2005.

3. 3. Sreekumar GP, Erf GF, Smyth JR Jr. 5-Azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo. Clin Immunol Immunopathol 81: 136-144, 1996.

4. Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

5. 5. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 10: 223-232, 2009.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation modification in Idiopathic pulmonary fibrosis;Frontiers in Cell and Developmental Biology;2024-06-10

2. Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management;Frontiers in Oncology;2024-02-09

3. Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database;Oncology;2023

4. Therapeutic induction of Bcl2‐associated athanogene 3‐mediated autophagy in idiopathic pulmonary fibrosis;Clinical and Translational Medicine;2022-07

5. Azacitidine-induced pneumonitis and literature review;BMJ Case Reports;2020-10